Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,214,347 papers from all fields of science
Search
Sign In
Create Free Account
neolactotetraosylceramide alpha-2,3-sialyltransferase
Known as:
CMP-N-acetylneuraminate-neolactotetraosylceramide alpha-2,3-sialyltransferase
, CMP-NeuAc-nLcOse4Cer alpha2,3sialyltransferase
, SAT-3 enzyme
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Sialyltransferases
neolactotetraosylceramide alpha-2,3-sialyltransferase activity
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Improved separation of isomeric gangliosides by anion-exchange high-performance liquid chromatography.
Johannes Müthing
,
F. Unland
Journal of chromatography. B, Biomedical…
1994
Corpus ID: 22810172
1994
1994
A comparative assessment of TLC overlay technique and microwell adsorption assay in the examination of influenza A and Sendai virus specificities towards oligosaccharides and sialic acid linkages of…
J. Müthing
,
F. Unland
Glycoconjugate Journal
1994
Corpus ID: 25662508
Influenza A and Sendai viruses bind toneolacto-series gangliosides isolated from human granulocytes. Differences in receptor…
Expand
1993
1993
Different binding capacities of influenza A and Sendai viruses to gangliosides from human granulocytes
J. Müthing
,
F. Unland
,
+8 authors
J. Lehmann
Glycoconjugate Journal
1993
Corpus ID: 22609859
The structures of gangliosides from human granulocytes were elucidated by fast atom bombardment mass spectrometry and by gas…
Expand
1985
1985
Monoclonal antibodies raised against NeuAc alpha 2-6neolactotetraosylceramide detect carcinoma-associated gangliosides.
O. Nilsson
,
L. Lindholm
,
J. Holmgren
,
L. Svennerholm
Biochimica et Biophysica Acta
1985
Corpus ID: 40722152
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE